Obama's decision led to the creation of several new projects involving stem-cells as well as the approval of 75 new stem cell lines by the U.S. National Institutes of Health. The ruling is being considered a large step backwards in terms of progress in the field of stem cell research.
Tim Kamp, the director of the University of Wisconsin Stem Cell and Regenerative Medicine Center says that Lamberth's ruling will be harmful to the United States' standing in the global market place. ''It will put us at a huge competitive disadvantage to other countries.'' Collins said that countries like Japan, the U.K., Australia and China were all among the countries making significant headway into the field.
Leonard I. Zon, director of the Stem Cell Program at Children's Hospital Boston, was very disheartened by the decision. Zon said that ''American scientists have been put at a disadvantage against their counterparts all over the world.''
Zon also expressed concern over the effects the ruling could have on the nation. ''The economic impact of this injunction on the United States could surely be huge. Scientists run increased risks of running afoul of the law and will be increasingly isolated from their colleagues overseas.'' Zon also wrote, ''We risk that the U.S. will fall increasingly behind.''
While appeals have already been filed with the courts, scientists have been given thus far just over $130 million in grants with which to conduct research during the current fiscal year. According to the NIH, they may continue to use those funds until they are depleted.